Los Angeles – Feb 6, 2024 – JoyLocks, a leading telemedicine company specializing in hair loss treatment, is excited to announce the launch of their new offering: Finasteride and Minoxidil Capsules. This addition to their product line complements their existing topical treatments, providing customers with a convenient alternative for managing hair loss. Key Features of […]
Tag: Pharmaceuticals & Biotech
Kymriah A Comprehensive Forecast on the Accelerating Market Growth for Acute Lymphoblastic Leukemia by 2030
The recently published in-depth report on Kymriah (Novartis) provides insights into the drug market landscape and market forecast of Kymriah upto 2030. [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Kymriah (Novartis) providing insights into the drug market landscape and market forecast of Kymriah upto […]
BioMarin Pharmaceutical’s Valrox (Valoctocogene Roxaparvovec) market size expected to increase many folds by 2032, report DelveInsight
The recently published in-depth report on Valrox (Valoctocogene Roxaparvovec) (BioMarin Pharmaceutical) provides insights into the drug market landscape and market forecast of Valrox (Valoctocogene Roxaparvovec) upto 2032. [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Valrox (Valoctocogene Roxaparvovec) (BioMarin Pharmaceutical) providing insights into the drug […]
Peanut Allergy Pipeline, FDA Approvals, Clinical Trials Assessment, Emerging Drugs, Latest News 2024 (Updated)
DelveInsight’s, “Peanut Allergy Pipeline Insight 2024” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Peanut Allergy pipeline landscape. It covers the Peanut Allergy Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Peanut Allergy Pipeline therapeutics assessment by product type, stage, route of administration, and molecule […]
RINVOQ by AbbVie Set to Experience Tremendous Growth by 2032.
RINVOQ (AbbVie) providing insights into the drug market landscape and market forecast of RINVOQ upto 2032. [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on RINVOQ (AbbVie) providing insights into the drug market landscape and market forecast of RINVOQ upto 2032. The report, titled “RINVOQ Market […]
Non-Alcoholic Fatty Liver Disease Pipeline, FDA Approvals, Research and Developments, Future Perspectives, and Companies (Updated)
DelveInsight’s, “Non-Alcoholic Fatty Liver Disease Pipeline Insight” report provides comprehensive insights about 110+ Non-Alcoholic Fatty Liver Disease companies and 160+ pipeline drugs in Non-Alcoholic Fatty Liver Disease pipeline landscape. It covers the Non-Alcoholic Fatty Liver Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non-Alcoholic Fatty Liver Disease pipeline therapeutics […]
Takeda’s “Darvadstrocel (ALOFISEL ) market size expected to increase many folds by 2032, reports DelveInsight
“ALOFISEL Market Size, Forecast, and Drug Insight – 2032” is published by DelveInsight, a leader in healthcare research firm, providing insights into the ALOFISEL market landscape and market forecast of ALOFISEL upto 2032. [Las Vegas, United States] Latest report, “ALOFISEL Market Size, Forecast, and Drug Insight – 2032” is published by DelveInsight, a leader in […]
Acurx Pharmaceuticals’ Phase 2b Results For Ibezapolstat Bests Standard Of Care Vancomycin To Treat C. Difficile ($ACXP)
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) stock may present an investment opportunity that is too good to ignore. That assessment is more than warranted; it’s justified, based on results from its Phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat, for treating patients with Clostridioides difficile Infection (C. difficile, CDI). The data is more than […]
Candidemia Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Cidara Therapeutics, Mundipharma, Pfizer
“Candidemia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Candidemia, historical and forecasted epidemiology as well as the Candidemia market trends in the 7MM. The Candidemia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Candidemia pipeline products […]
Endocarditis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Lysovant, ContraFect, Basilea Pharmaceuticals
“Endocarditis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Endocarditis, historical and forecasted epidemiology as well as the Endocarditis market trends in the 7MM. The Endocarditis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Endocarditis pipeline products […]